EBITDA: Income before interest, taxes, depreciation and amortization.
Apyx Medical Corporation (APYX) had EBITDA of $-0.71M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$12.49M |
|
$-2.11M |
|
$4.57M |
|
$7.92M |
|
$13.40M |
|
$-0.91M |
|
$-1.09M |
|
$-2.00M |
|
$-2.04M |
|
$-2.14M |
|
$-2.14M |
|
$-2.14M |
|
$-2.18M |
|
$-0.91M |
|
|
EBITDA |
$-0.71M |
43.74M |
|
43.74M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$54.80M |
|
$2.23M |
|
$8.23M |
|
$63.02M |
|
$9.45M |
|
$35.09M |
|
$40.49M |
|
$49.94M |
|
$13.09M |
|
$13.09M |
|
$13.09M |
|
41.87M |
|
| Cash Flow Statement Financials | |
$-0.57M |
|
$-0.06M |
|
$0.08M |
|
$31.74M |
|
$31.14M |
|
$-0.60M |
|
$0.31M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.80 |
|
-- |
|
-- |
|
0.73 |
|
2.68 |
|
63.45% |
|
-7.29% |
|
-7.29% |
|
-- |
|
-16.01% |
|
-16.88% |
|
$-0.63M |
|
-- |
|
-- |
|
-- |
|
0.20 |
|
0.48 |
|
0.98 |
|
91.91 |
|
-16.37% |
|
-16.37% |
|
-3.40% |
|
-4.45% |
|
$0.31 |
|
$-0.01 |
|
$-0.01 |
|